Funding for this research was provided by:
Roparun Foundation (n.a.)
Received: 19 August 2019
Accepted: 28 August 2020
First Online: 9 September 2020
Ethics approval and consent to participate
: The study will be conducted according to the declaration of Helsinki. The study protocol is reviewed by the Medical Ethical Committee of the Dutch Cancer Institute (NKI) in Amsterdam, the Netherlands (METC17.1491). The METC has exempted this observational research from ethical review, accordingly to the Dutch Medical Research Involving Human Subjects Act (WMO). Furthermore, in data collection and analyses procedures, the rules of Dutch Personal Data Protection Act and the General Data Protection Regulation (GDPR) will be followed. In all collaborating hospitals, local scientific committees, if present, will be contacted to get local approval and a check for competitive studies will be done in consultation with the concerning department. Written informed consent will be obtained from all study participants.
: Not applicable.
: The authors declare that they have no competing interests.